Skip to content

Thymosin beta-4 (human) studies: 835 papers with results

Page 3 of 17

  1. Thymosin beta 4 synergizes with human granulocyte-macrophage colony-stimulating factor in maintaining bone marrow proliferation.

    Moscinski LC · Immunopharmacology · 1993

    Animal study (in vivo) · mouse · 6 results

  2. Thymosin beta 4 prevents systemic lipopolysaccharide-induced plaque load in middle-age APP/PS1 mice.

    Othman O · International immunopharmacology · 2023

    Animal study (in vivo) · mouse · 4 results

  3. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.

    Zeng PM · Stem cell reports · 2025

    Animal study (in vivo) · mouse · 5 results

  4. Upregulated Tβ4 expression in inflammatory bowel disease impairs the intestinal mucus barrier by inhibiting autophagy in mice.

    Hao M · Experimental cell research · 2024

    Animal study (in vivo) · mouse · 8 results

  5. Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm delivery.

    Faa G · European review for medical and pharmacological sciences · 2021

    Animal study (in vivo) · mouse · 6 results

  6. Thymosin β4 enhances the healing of medial collateral ligament injury in rat.

    Xu B · Regulatory peptides · 2013

    Animal study (in vivo) · rat · 4 results

  7. Prelimbic cortex to ventral tegmental area projection regulates early social isolation stress-potentiated heroin seeking in mice.

    Wang Y · Nature communications · 2025

    Animal study (in vivo) · mouse · 3 results

  8. Plasmacytoid dendritic cells alleviate allergic asthma via airway epithelial cell-dependent thymosin β4 expression.

    Li Y · The Journal of allergy and clinical immunology · 2025

    Animal study (in vivo) · mouse · 11 results

  9. Detection and quantification of the metabolite Ac-Tβ1-14 in in vitro experiments and urine of rats treated with Ac-Tβ4: A potential biomarker of Ac-Tβ4 for doping tests.

    Rahaman KA · Drug testing and analysis · 2023

    Animal study (in vivo) · rat · 8 results

  10. Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway.

    Yu R · International journal of molecular sciences · 2023

    Animal study (in vivo) · mouse · 5 results

  11. Effects of thymosin β4 on the bone formation of calvarial defects in rats.

    Adachi K · Journal of prosthodontic research · 2013

    Animal study (in vivo) · wistar rat · 4 results

  12. The Escherichia coli-derived thymosin β4 concatemer promotes cell proliferation and healing wound in mice.

    Wang X · BioMed research international · 2013

    Animal study (in vivo) · mouse · 3 results

  13. Effects of thymosin β4 on a rat model of severe acute pancreatitis.

    He X · Experimental and therapeutic medicine · 2015

    Animal study (in vivo) · rat · 7 results

  14. Thymosin β4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome.

    Sun YS · World journal of gastroenterology · 2025

    Animal study (in vivo) · mouse and rat · 8 results

  15. Thymosin β4 Exerts a Cytoprotective Function and Attenuates Liver Injury in Murine Hepatic Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.

    Wang X · Transplantation and cellular therapy · 2023

    Animal study (in vivo) · mouse · 26 results

  16. The use of angiogenic-antimicrobial agents in experimental wounds in animals: problems and solutions.

    Suman P · Annals of the New York Academy of Sciences · 2012

    Animal study (in vivo) · rat · 5 results

  17. Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway.

    Ouyang X · Clinical science (London, England : 1979) · 2026

    Animal study (in vivo) · mouse · 7 results

  18. Thymosin β4 Regulates Tissue Inflammatory Response in Mouse Nonalcoholic Fatty Liver Disease by Promoting Macrophage M2-Type Polarization.

    Zhu Z · Journal of inflammation research · 2025

    Animal study (in vivo) · mouse · 7 results

  19. Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals.

    Maar K · International journal of molecular sciences · 2025

    Animal study (in vivo) · mouse · 5 results

  20. Effects of Thymosin β4 on Myocardial Apoptosis in Burned Rats.

    Wu X · Journal of healthcare engineering · 2022

    Animal study (in vivo) · rat · 3 results

  21. Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.

    Liu J · BMC ophthalmology · 2022

    Animal study (in vivo) · mouse · 9 results

  22. A Tobacco-Derived Thymosin β4 Concatemer Promotes Cell Proliferation and Wound Healing in Mice.

    Janarthini R · BioMed research international · 2016

    Animal study (in vivo) · mouse · 3 results

  23. Efficiency of recombinant thymosin β4 in spontaneous mouse model of chronic dermatitis.

    Moiseeva EV · Bulletin of experimental biology and medicine · 2015

    Animal study (in vivo) · mouse · 2 results

  24. Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling.

    Zhao TR · Molecular biomedicine · 2026

    Animal study (in vivo) · mouse · 10 results

  25. Thymosin β4 Mitigates Acute Cerebral Infarction Via Inhibition of the TLR4/NF-κB Pathway and Suppression of Neuronal Pyroptosis.

    Zhang Z · Applied biochemistry and biotechnology · 2026

    Animal study (in vivo) · rat · 14 results

  26. Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses.

    Ye Y · Biomolecules · 2026

    Animal study (in vivo) · mouse · 10 results

  27. PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo.

    Peng H · Bioengineering & translational medicine · 2026

    Animal study (in vivo) · 4 results

  28. Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway.

    Yu R · The Journal of pharmacy and pharmacology · 2025

    Animal study (in vivo) · mouse · 6 results

  29. Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4 during Pseudomonas aeruginosa-induced keratitis.

    Wang Y · Frontiers in immunology · 2024

    Animal study (in vivo) · 4 results

  30. Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway.

    Zhang X · Free radical biology & medicine · 2025

    Other design · 7 results

  31. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro.

    Rubin BK · Chest · 2006

    Ex vivo tissue · 7 results

  32. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

    Smart N · Nature · 2007

    Ex vivo tissue · 5 results

  33. Thymosin stimulates secretion of luteinizing hormone-releasing factor.

    Rebar RW · Science (New York, N.Y.) · 1981

    Ex vivo tissue · rat · 2 results

  34. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis.

    Grant DS · Angiogenesis · 1999

    Ex vivo tissue · 8 results

  35. The actin binding site on thymosin beta4 promotes angiogenesis.

    Philp D · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2003

    Ex vivo tissue · chicken · 7 results

  36. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.

    Kumar N · American journal of physiology. Renal physiology · 2016

    Ex vivo tissue · mouse and rat · 3 results

  37. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.

    Kater A · Annals of the New York Academy of Sciences · 2007

    Ex vivo tissue · 3 results

  38. Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages.

    Tzehoval E · Immunopharmacology · 1989

    Ex vivo tissue · mouse · 10 results

  39. Derivation of epicardium-derived progenitor cells (EPDCs) from adult epicardium.

    Smart N · Current protocols in stem cell biology · 2009

    Ex vivo tissue · 1 result

  40. Epicardial slices: an innovative 3D organotypic model to study epicardial cell physiology and activation.

    Maselli D · NPJ Regenerative medicine · 2022

    Ex vivo tissue · pig · 4 results

  41. Formation of acetyl-Ser-Asp-Lys-Pro, a new regulator of the hematopoietic system, through enzymatic processing of thymosin beta 4.

    Lenfant M · Annals of the New York Academy of Sciences · 1991

    Ex vivo tissue · 4 results

  42. Ectopic Expression of Human Thymosin β4 Confers Resistance to Legionella pneumophila during Pulmonary and Systemic Infection in Mice.

    Park B · Infection and immunity · 2021

    Ex vivo tissue · mouse · 13 results

  43. Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals.

    Bako P · International immunopharmacology · 2023

    Ex vivo tissue · mouse · 2 results

  44. Development of an analytical HPLC methodology to study the effects of thymosin β4 on actin in sputum of cystic fibrosis patients.

    Badamchian M · Annals of the New York Academy of Sciences · 2012

    Ex vivo tissue · 4 results

  45. Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte function.

    Elitsur Y · Immunopharmacology · 1990

    In vitro (cells) · 6 results

  46. Antimicrobial peptides from human platelets.

    Tang YQ · Infection and immunity · 2002

    In vitro (cells) · e. coli, s. aureus and c. albicans · 5 results

  47. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.

    Lamaze C · The Journal of biological chemistry · 1997

    In vitro (cells) · 3 results

  48. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

    Sosne G · Experimental eye research · 2007

    In vitro (cells) · 4 results

  49. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

    Sanders MC · Proceedings of the National Academy of Sciences of the United States of America · 1992

    In vitro (cells) · 2 results

  50. Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system.

    Grillon C · FEBS letters · 1990

    In vitro (cells) · 3 results

How PepBank reports evidence